Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Jones, Richard J  [Clear All Filters]
2024
Imus PHollingswo, Pasca S, Tsai H-L, Aljawai Y, Cooke KR, Walston JD, Gocke CD, Varadhan R, Jones RJ, Gondek LP. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024.
2023
Ghiaur G, Valkenburg KC, Esteb C, Ambinder A, Imus PH, Pienta KJ, Jones RJ. Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4. Cancer. 2023.
Bolaños-Meade J, Hamadani M, Wu J, Malki MMAl, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, et al. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. N Engl J Med. 2023;388(25):2338-2348.
2022
O'Donnell PV, Jones RJ. The development of post-transplant cyclophosphamide: Half a century of translational team science. Blood Rev. 2022:101034.
2021
Sterling CH, Tsai H-L, Holdhoff M, Bolaños-Meade J, Luznik L, Fuchs EJ, Huff CAnn, Gocke CB, Ali SAbbas, Borrello IM, et al. "Allogeneic blood or marrow transplant with non-myeloablative conditioning and high dose cyclophosphamide-based graft-versus-host disease prophylaxis for secondary central nervous system lymphoma". Transplant Cell Ther. 2021.
Rappazzo KC, Zahurak M, Bettinotti M, Ali SAbbas, Ambinder AJ, Bolaños-Meade J, Borrello I, DeZern AE, Gladstone D, Gocke C, et al. Nonmyeloablative, HLA-mismatched unrelated peripheral blood transplantation with high-dose posttransplantation cyclophosphamide. Transplant Cell Ther. 2021.
2020
Wagner-Johnston ND, Hannum SM, Heughan JA-A, Abshire M, Wolff JL, Yarkony K, Symons H, Jones RJ, Dy SM. Assessing Early Supportive Care Needs Among Son or Daughter Haploidentical Transplantation Donors. Biol Blood Marrow Transplant. 2020.
Yanagisawa B, Perkins B, Karantanos T, Levis M, Ghiaur G, B Smith D, Jones RJ. Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes. Leuk Res. 2020;99:106477.
DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, Huff CAnn, Swinnen LJ, Imus P, Borrello I, et al. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Adv. 2020;4(8):1770-1779.
2019
Karantanos T, Jones RJ. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance. Adv Exp Med Biol. 2019;1139:153-169.
Imus PH, Blackford AL, Bettinotti M, Luznik L, Fuchs EJ, Huff CAnn, Gladstone DE, Ambinder RF, Borrello IM, Fuchs RJ, et al. Severe cytokine release syndrome after haploidentical peripheral blood transplantation. Biol Blood Marrow Transplant. 2019.
2018
DeZern AE, Jones RJ, Brodsky RA. Eculizumab Bridging Before Bone Marrow Transplant for Marrow Failure Disorders is Safe and Does Not Limit Engraftment. Biol Blood Marrow Transplant. 2018.
2016
Shelton BK, Stanik-Hutt J, Kane J, Jones RJ. Implementing the Surviving Sepsis Campaign in an Ambulatory Clinic for Patients With Hematologic Malignancies. Clin J Oncol Nurs. 2016;20(3):281-288.
2015
Su M, Alonso S, Jones JW, Yu J, Kane MA, Jones RJ, Ghiaur G. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment. PLoS One. 2015;10(6):e0127790.
2013
Ghiaur G, Yegnasubramanian S, Perkins B, Gucwa JL, Gerber JM, Jones RJ. Regulation of human hematopoietic stem cell self-renewal by the microenvironment's control of retinoic acid signaling. Proc Natl Acad Sci U S A. 2013.